대한핵의학회지 (1967년~2009년)
대한핵의학회지 2001;35(5)293~8
종설 : 188Re 표지 방사성의약품 ( Review : 188Re - Labeled Radiopharmaceuticals )
()
Author 정재민(Jae Min Jeong),
Affiliation
Abstract

The search for an ideal radioisotope for radiotherapy continues. As a generator - produced radioisotope emitting both beta and gamma rays with a short physical half-life of 16.9 hr. 188 Re in an excellent candidate for radiotherapy. Its applications include the irradiation of coronary artery to prevent restenosis, treatment of rheumatoid arthritis, treatment of peritonedal effusion, palliation of metastatic bone pain, and treatment of liver cancer. ( Korean J Nucl Med 2001;35:293-300)

Keyword 188Re , radionuclide therapy
Full text Article 28503363.pdf 28503363.pdf
(03121)서울시 종로구 지봉로 29 금호팔레스빌딩 1705호
TEL : 02-745-2040 FAX : 02-745-3833 E-mail : ksnm@ksnm.or.kr
Copyright 2012 by The Korean Society of Nuclear Medicine(KSNM)